论文部分内容阅读
上半年全国中药交流会上提供的信息,国有药材(医药)公司库存普遍薄弱,市场行情多呈涨势;中药市场虽有好转,但经营仍较艰难。在这次会上,药材统货成交行情(元/千克)如下: 趋升品种:银花44元、小芽皂13元、连丹皮25～26元、半枝莲5.2元、黄芩14.5元、桑叶2.8元、附子片17.2元、白茅根3.9元、玄参6元、干姜片9.8元、侧柏叶3.2元、红莲米24元、土元46元、家桃仁27元、杏仁17元、虫蜕20元、蛇床子
In the first half of the year, the information provided by China National Traditional Chinese Medicine Exchange Conference showed that stocks of state-owned medicinal herbs (pharmaceuticals) companies were generally weak and the market conditions were mostly up. The Chinese medicine market was still improving, but the operation was still rather difficult. In this meeting, the actual transaction price (yuan / kg) of medicinal materials is as follows: Ascending varieties: Yinhua 44 yuan, small bud soap 13 yuan, Lianbandi 25 ~ 26 yuan, Scutellaria barbata 5.2 yuan, Scutellaria 14.5 yuan, Mulberry leaf 2.8 yuan, aconite piece 17.2 yuan, Rhizoma Imperatae 3.9 yuan, 6 yuan Scrophulariaceae, ginger 9.8 yuan, Arborvitae leaf 3.2 yuan, 24 yuan Honglianmi, 46 yuan soil yuan, 27 yuan peach kernel, almond 17 Yuan, insect shed 20 yuan, Cnidium